Abstract
Decisions were made at the last Council meeting of EMBL (European Molecular Biology Laboratory) that are strategically important to the development of biotechnology in the member states. The Council has planned the construction of an International Technology Transfer Centre (ITTC) on the EMBL campus in Heidelberg (Germany) (due to be completed by June 2002), to ensure that key research findings and technological innovations from the institution can move to industry in an efficient way. A commercial investment fund, named the Technology Transfer Fund, has also been established and is expected to provide funding mainly for EMBL-associated biotech start-up companies.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
